{
  "id": 14466115,
  "title": "Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment",
  "url": "https://urgent.news/2026/10/14/oncolytics-biotech-provides-update-on-goblet-study-clinical-data-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-14T14:14:28.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/oncolytics-biotech-provides-update-on-goblet-study-clinical-data-and-final-pancan-grant-payment"
  },
  "original_language": "en",
  "account": null,
  "summary": "Completion of enrollment earlier this year and expected final PanCAN grant payment this quarter mark successful completion of a key phase of Cohort 5 Final Cohort 4 results expected in Q4 2026; initial Cohort 5 results expected in the first half of 2027 The Company will use the clinical data to focus and guide its […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}